Aurisco Pharmaceutical Co Ltd (605116.SS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE1000042S4
Aurisco Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.48 bn CNY | 1.70 bn CNY |
| Gross profit | 844.36 m CNY | 1.01 bn CNY |
| Operating income | 410.50 m CNY | 559.38 m CNY |
| EBIT | 424.19 m CNY | 553.01 m CNY |
| Net income | 354.79 m CNY | 449.21 m CNY |
| Diluted EPS – continuing operations | 0.89 CNY | 1.11 CNY |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Aurisco Pharmaceutical Co Ltd
Aurisco Pharmaceutical Co.,Ltd. engages in the research, development, production and sales of special complex APIs, pharmaceutical intermediates and preparations worldwide. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs. It also provides eplerenone, an API to treat cardiovascular diseases, lowering blood pressure, and treating heart failure; futicasone propionate, used for the treatment of asthma, respiratory tract diseases, and rhinitis; Tenofovir, an anti-infection used to treat AIDS and hepatitis B; pregabalin for the treatment of anti-epileptic, analgesic, and anti-anxiety purposes, as well as for neuralgia; abiraterone acetate to treat prostate cancer; and dydrogesterone, to treat endogenous for women's heath. Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.
More stocks
- JPG (5323.KL)
- Capitol Federal Financial, Inc. (CFFN)
- Innovative Medical Management Co Ltd (002173.SZ)
- CNB FINANCIAL CORP/PA (CCNE)
- Compagnie des Alpes SA (CDA.PA)
- Janux Therapeutics, Inc. (JANX)
- Zhongli Science and Technology Group Co Ltd (002309.SZ)
- Cpi Fim SA (OPG.WA)
- Brilliance China Automotive Holdings Ltd (1114.HK)
- Medincell SA (MEDCL.PA)
- Simply Good Foods Co (SMPL)
- Multipolar Technology Tbk (MLPT.JK)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.